Takeda UK Limited is a ltd company established in 1997, operating as a global biopharmaceutical organization dedicated to improving patient lives. Based at 1 Kingdom Street, London, W2 6BD, Takeda focuses on the discovery, development, and commercialization of innovative medicines. The company’s core mission centers on addressing unmet medical needs through research and development, with a strong emphasis on patient-centricity. Takeda’s activities encompass a broad spectrum of pharmaceutical solutions, including prescription drugs, biosimilars, and specialized products. The company’s international presence is significant, with operations spanning across numerous countries and regions worldwide. Takeda actively pursues strategic partnerships and collaborations to expand its reach and impact. As a global business mobility visa holder, Takeda UK Limited is classified as a Worker (A rating). The company’s primary focus is on pharmaceutical innovation, driven by a commitment to scientific advancement and patient well-being. Takeda’s international operations are a key element of its strategy, contributing to a global healthcare landscape. The company’s activities are aligned with the SIC codes - 46460: Wholesale of pharmaceutical goods and potentially other relevant industry classifications.

Takeda UK Limited is a ltd company established in 1997, operating as a global biopharmaceutical organization dedicated to improving patient lives. Based at 1 Kingdom Street, London, W2 6BD, Takeda focuses on the discovery, development, and commercialization of innovative medicines. The company’s core mission centers on addressing unmet medical needs through research and development, with a strong emphasis on patient-centricity. Takeda’s activities encompass a broad spectrum of pharmaceutical solutions, including prescription drugs, biosimilars, and specialized products. The company’s international presence is significant, with operations spanning across numerous countries and regions worldwide. Takeda actively pursues strategic partnerships and collaborations to expand its reach and impact. As a global business mobility visa holder, Takeda UK Limited is classified as a Worker (A rating). The company’s primary focus is on pharmaceutical innovation, driven by a commitment to scientific advancement and patient well-being. Takeda’s international operations are a key element of its strategy, contributing to a global healthcare landscape. The company’s activities are aligned with the SIC codes - 46460: Wholesale of pharmaceutical goods and potentially other relevant industry classifications.